WO2024003143 - MUTANASES AND ORAL CARE COMPOSITIONS COMPRISING SAME
National phase entry is expected:
Publication Number
WO/2024/003143
Publication Date
04.01.2024
International Application No.
PCT/EP2023/067662
International Filing Date
28.06.2023
Title **
[English]
MUTANASES AND ORAL CARE COMPOSITIONS COMPRISING SAME
[French]
MUTANASES ET COMPOSITIONS D'HYGIÈNE BUCCALE LES COMPRENANT
Applicants **
NOVOZYMES A/S
Inventors
TIWARI, Manish, Kumar
SEGURA, Dorotea, Raventos
STRINGER, Mary, Ann
PALMÉN, Lorena, González
SALOMON, Jesper
Priority Data
22182248.9
30.06.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2792 | |
| EPO | Filing, Examination, Granting | 11280 | |
| Japan | Filing, Examination, Granting | 2172 | |
| South Korea | Filing, Examination, Granting | 2039 | |
| USA | Filing, Examination, Granting | 8190 |
Total:
26,473
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to polypeptides having endo-1,3-α-glucanase activity, polynucleotides encoding the polypeptides, nucleic acid constructs, vectors, host cells comprising the polynucleotides, methods of producing the polypeptides, as well as oral care compositions comprising the polypeptides.[French]
La présente invention concerne des polypeptides ayant une activité endo-1,3-alpha-glucanase, des polynucléotides codant pour les polypeptides, des constructions d'acide nucléique, des vecteurs, des cellules hôtes comprenant les polynucléotides, des procédés de production des polypeptides, ainsi que des compositions d'hygiène buccale comprenant lesdits polypeptides.